CCM
MNTA

Crabel Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Crabel Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-9,588
Closed -$503K – 97
2020
Q3 		$503K Buy
+9,588
New +$397K 1% 25

Crabel Capital Management's MNTA Position: Q4 2020 in Review

Crabel Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 9,588 shares — an estimated $503K sold.

Crabel Capital Management first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $503K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Crabel Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Crabel Capital Management sold 9,588 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $503K.
  • Crabel Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Crabel Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $503K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Crabel Capital Management's 13F filing for Q4 2020, filed 9 Feb 2021.